Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 345

Results For "NDA"

4746 News Found

Roche's Elecsys Amyloid Plasma Panel granted FDA breakthrough device designation to enable a timely diagnosis of Alzheimer’s disease
News | July 20, 2022

Roche's Elecsys Amyloid Plasma Panel granted FDA breakthrough device designation to enable a timely diagnosis of Alzheimer’s disease

The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.


Essential Pharma progress in its ESG performance
Sustainability | July 20, 2022

Essential Pharma progress in its ESG performance

The company now exceeds the sector benchmark for its overall ESG rating and for all three measures


Lupin Diagnostics launches its first reference laboratory in Ranchi
Clinical Trials | July 19, 2022

Lupin Diagnostics launches its first reference laboratory in Ranchi

Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies


Pharma manufacturer 'Gansons' turns 75
News | July 18, 2022

Pharma manufacturer 'Gansons' turns 75

Gansons is based in Thane (Maharashtra, India) with global representation in UK, USA, UAE, Central Asia, South Asia and South-East Asia.


India crosses ‘200 Crore’ COVID-19 vaccinations
News | July 18, 2022

India crosses ‘200 Crore’ COVID-19 vaccinations

PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive


NHA commences first Hackathon under the ‘ABDM Hackathon Series’ in Pune
News | July 18, 2022

NHA commences first Hackathon under the ‘ABDM Hackathon Series’ in Pune

ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event


Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD
People | July 18, 2022

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD

Manish led SeQuent since 2014 and played a major role in transforming the company


Zydus receives final approval from the USFDA for Efinaconazole Topical Solution
Drug Approval | July 18, 2022

Zydus receives final approval from the USFDA for Efinaconazole Topical Solution

Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).


Think twice even before you start thinking on smoking!
Opinion | July 18, 2022

Think twice even before you start thinking on smoking!

Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs